Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' PECORA AL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 40 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Preti, RA; Lazarus, HM; Winter, J; Stadtmauer, EA; Nadasi, S; McMannis, J; Karandish, S; Jennis, A; Goldberg, SL; Pecora, AL
      Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer

      CYTOTHERAPY
    2. Pecora, AL
      Progress in clinical application of use of progenitor cells expanded with hematopoietic growth factors

      CURRENT OPINION IN HEMATOLOGY
    3. Menillo, SA; Goldberg, SL; McKiernan, P; Pecora, AL
      Intraoral psoralen ultraviolet A irradiation (PUVA) treatment of refractory oral chronic graft-versus-host disease following allogeneic stem cell transplantation

      BONE MARROW TRANSPLANTATION
    4. Pecora, AL; Stiff, P; LeMaistre, CF; Bayer, R; Bachier, C; Goldberg, SL; Parthasarathy, M; Jennis, AA; Smith, AK; Douville, J; Chen, B; Armstrong, RD; Mandalam, RK; Preti, R
      A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    5. Pecora, AL; Lazarus, HM; Stadtmauer, EA; Winter, J; Van Vliet, A; Berry, D; Gray, R; Jennis, A; Goldberg, S; Cooper, BW; Preti, R
      Effect of induction chemotherapy and tandem cycles of high-dose chemotherapy on outcomes in autologous stem cell transplant for metastatic breast cancer

      BONE MARROW TRANSPLANTATION
    6. Nieto, Y; Champlin, RE; Wingard, JR; Vredenburgh, JJ; Elias, AD; Richardson, PR; Glaspy, J; Jones, RB; Stiff, PJ; Bearman, SI; Cagnoni, PJ; McSweeney, PA; LeMaistre, CF; Pecora, AL; Shpall, EJ
      Status of high-dose chemotherapy for breast cancer: A review

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    7. Goldberg, SL; Pecora, AL; Rosenbluth, RJ; Jennis, AA; Preti, RA
      Treatment of leukemic relapse following unrelated umbilical cord blood transplantation with interleukin-2: potential for augmenting graft-versus-leukemia and graft-versus-host effects with cytokines

      BONE MARROW TRANSPLANTATION
    8. Pecora, AL; Stiff, P; Jennis, A; Goldberg, S; Rosenbluth, R; Price, P; Goltry, KL; Douville, J; Armstrong, RD; Smith, AK; Preti, RA
      Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulatedunrelated umbilical cord blood

      BONE MARROW TRANSPLANTATION
    9. Lazarus, HM; Pecora, AL; Shea, TC; Koc, ON; White, JM; Gabriel, DA; Cooper, BW; Gerson, SL; Krieger, M; Sing, AP
      CD34(+) selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcome

      BONE MARROW TRANSPLANTATION
    10. Preti, RA; Pecora, AL; Ahmed, T; Farley, TJ
      CD34 selection using immunomagnetic beads

      HEMATOPOIETIC STEM CELL TRANSPLANTION
    11. Pecora, AL
      Impact of stem cell dose on hematopoietic recovery in autologous blood stem cell recipients

      BONE MARROW TRANSPLANTATION
    12. Rowlings, PA; Williams, SF; Antman, KH; Fields, KK; Fay, JW; Reed, E; Pelz, CJ; Klein, JP; Sobocinski, KA; Kennedy, MJ; Freytes, CO; McCarthy, PL; Herzig, RH; Stadtmauer, EA; Lazarus, HM; Pecora, AL; Bitran, JD; Wolff, SN; Gale, RP; Armitage, JO; Vaughan, WP; Spitzer, G; Horowitz, MM
      Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    13. Shpall, EJ; Wheeler, CA; Turner, SA; Yanovich, S; Brown, RA; Pecora, AL; Shea, TC; Mangan, KF; Williams, SF; LeMaistre, CF; Long, GD; Jones, R; Davis, MW; Murphy-Filkins, R; Parker, WRL; Glaspy, JA
      A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients

      BLOOD
    14. PECORA AL; NEGRIN RS
      CD34 ENUMERATION

      Journal of hematotherapy
    15. PRETI RA; ZAHOS KM; JENNIS AA; MURAWSKI J; NADASI S; DORIA L; ISAACS RE; BROCHSTEIN JA; PECORA AL
      EFFECT OF INTERFACE OFFSET (I/O) ADJUSTMENT ON COLLECTION EFFICIENCY USING THE FENWAL CS3000 PLUS BLOOD-CELL SEPARATOR FOR PERIPHERAL-BLOODPROGENITOR-CELL COLLECTION/

      Journal of hematotherapy
    16. PECORA AL; PRETI RA; GLEIM GW; JENNIS A; ZAHOS K; CANTWELL S; DORIA L; ISAACS R; GILLIO AP; MICHELIS MA; BROCHSTEIN JA
      CD34(-) CELLS INFLUENCE DAYS TO ENGRAFTMENT AND TRANSFUSION REQUIREMENTS IN AUTOLOGOUS BLOOD STEM-CELL RECIPIENTS()CD33()

      Journal of clinical oncology
    17. LEMAISTRE CF; SHPALL EJ; TURNER SA; WHEELER CA; YANOVICH S; BROWN RA; PECORA AL; DAVIS MW; PARKER W; GLASPY JA
      PBPC MOBILIZATION - THE BENEFITS OF STEM-CELL FACTOR (SCF, STEMGEN(R)) AND AN OPTIMAL CD34(+) CELL YIELD

      British Journal of Haematology
    18. PRETI RA; NADASI S; MURAWSKI J; MCMANNIS J; KARANDISH S; PECORA AL
      SINGLE-STEP POSITIVE NEGATIVE PURGING FOR BREAST-CANCER AND T-LYMPHOCYTE DEPLETION USING THE BAXTER ISOLEX(R)300I MAGNETIC CELL SEPARATOR (ISOLEX(R)300I)/

      Blood
    19. COPELAN E; COOPER B; KENNEDY MJ; MEAGHER R; PECORA AL; PRETI RA; MOREB J; WINGARD J; HERZIG RM; UMIEL T; ROSENFELD C; LAZARUS HM; GLASSCO JE; KAHN DG; MOSS TJ
      THE PROGNOSTIC VALUE OF IMMUNOCYTOCHEMICAL (ICC) ANALYSIS ON BONE-MARROW (BM) TAKEN FROM PATIENTS WITH STAGE-IV BREAST-CANCER UNDERGOING AUTOLOGOUS TRANSPLANT (ABMT) THERAPY

      Blood
    20. UMIEL T; COOPER B; KENNEDY MJ; MEAGHER R; PECORA AL; ROSENFELD C; HERZIG RM; COPELAN E; LAZARUS HM; MOSS TJ
      THE PROGNOSTIC VALUE OF IMMUNOCYTOCHEMICAL (ICC) ANALYSIS ON BONE-MARROW (BM) TAKEN FROM PATIENTS WITH STAGE II III BREAST-CANCER UNDERGOING AUTOLOGOUS TRANSPLANT (ABMT) THERAPY/

      Blood
    21. PECORA AL; LAZARUS HM; COOPER B; KENNEDY MJ; UMIEL T; MEAGHER R; HERZIG RM; COPELAN E; PRILUTSKAYA M; GLASCO J; KAHN DG; MOSS TJ
      BREAST-CANCER CONTAMINATION IN PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS ASSOCIATION WITH BONE-MARROW DISEASE AND TYPE OF MOBILIZATION

      Blood
    22. KAHN DG; PRILUTSKAYA M; COOPER B; KENNEDY MJ; MEAGHER R; PECORA AL; PETRI RA; MOREB J; WINGARD J; ROSENFELD C; HERZIG RM; GLASSCO JE; UMIEL T; COPELAN E; LAZARUS HM; MOSS TJ
      THE RELATIONSHIP BETWEEN THE INCIDENCE OF TUMOR CONTAMINATION AND NUMBER OF PHERESIS FOR STAGE-IV BREAST-CANCER

      Blood
    23. SHPALL EJ; WHEELER CA; TURNER SA; YANOVICH S; BROWN RA; PECORA AL; SHEA TC; MANGAN KF; WILLIAMS SF; LEMAISTRE CF; LONG GD; MURPHYFILKINS R; PARKER W; GLASPY JA
      A RANDOMIZED PHASE-3 STUDY OF PBPC MOBILIZATION BY STEM-CELL FACTOR (SCF, STEMGEN(R)) AND FILGRASTIM IN PATIENTS WITH HIGH-RISK BREAST-CANCER

      Blood
    24. ISAACS RE; JENNIS A; ZAHOS K; CANTWELL S; ROSETI S; DORIA L; CORCORAN S; MURPHY L; WISNIEWSKI AM; MICHELIS MA; PECORA AL
      CYTOKINES FOR PRIMING AND MOBILIZATION OF PERIPHERAL-BLOOD PROGENITORCELLS (PBPC) IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY (HDC) WITHPERIPHERAL STEM-CELL TRANSPLANTATION (PSCT) - SEQUENTIAL ADMINISTRATION OF RHGM-CSF AND RHG-CSF VERSUS RHG-CSF ALONE

      Blood
    25. SCHENKEIN DP; ROITMAN D; MILLER KB; MORELLI J; STADTMAUER E; PECORA AL; CASSILETH P; LAZARUS HM
      A PHASE-II TRIAL OF FILGRASTIM (G-CSF) SUPPORTED HIGH-DOSE SEQUENTIALCHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION ASINITIAL THERAPY FOR HIGH-RISK NON-HODGKINS LYMPHOMA(NHL) - A MULTICENTER PILOT-STUDY

      Blood
    26. MOSS TJ; COOPER B; KENNEDY MJ; MEAGHER R; PECORA AL; HERZIG RM; UMIEL T; COPELAN E; AKARD L; JANSEN J; CARRUM G; LAZARUS HM
      THE PROGNOSTIC VALUE OF IMMUNOCYTOCHEMICAL (ICC) ANALYSIS ON BONE-MARROW (BM) TAKEN FROM PATIENTS WITH STAGE IV BREAST-CANCER UNDERGOING AUTOLOGOUS TRANSPLANT (ABMT) THERAPY

      Blood
    27. JENNIS A; PECORA AL; ISAACS RE; CANTWELL S; MICHELIS AM; ZAHOS K
      DOSE-INTENSIVE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND PLATINUM (DICEP) AS APRIMING MOBILIZATION REGIMEN FOR PERIPHERAL-BLOOD STEM-CELL (PBSC) HARVESTING PRIOR TO HIGH-DOSE CHEMOTHERAPY (HDC)/

      Blood
    28. UMIEL T; PECORA AL; LAZARUS H; COOPER B; COPELAN E; HERZIG R; MEAGHER R; KENNEDY MJ; CARRUM G; AKARD L; JANSEN J; ISSAC R; MOSS TJ
      BREAST-CANCER CONTAMINATION IN PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS ASSOCIATED WITH BONE-MARROW DISEASE AND TYPE OF MOBILIZATION REGIMEN

      Blood
    29. PECORA AL; LAZARUS H; COOPER B; COPELAN E; HERZIG R; MEAGHER R; KENNEDY J; AKARD L; JANSEN J; ISAACS R; JENNIS A; MOSS TJ
      THE INCIDENCE OF BREAST-CANCER CELL CONTAMINATION IN PERIPHERAL-BLOODSTEM-CELL (PBSC) COLLECTIONS IN RELATION TO THE MOBILIZATION REGIMEN

      Blood
    30. ELLIS GK; HUTCHINS L; JIMENEZMARTIN M; PECORA AL; BARNADAS A; MEISENBERG B; NABHOLTZ JM; CORTESFUNES H; RIFKIN R; CHANG AYC; GARRISON L; GEORGE C; GILES FJ
      PHASE-III DOUBLE-BLIND RANDOMIZED STUDY OF PIXY321 VERSUS GCSF AFTER CEP FOR BREAST OR OVARIAN-CARCINOMA

      Blood
    31. PECORA AL; ZAHOS KM; JENNIS A; ISAACS RE; CANTWELL S; MICHELIS AM; GILLIO AP; BROCHSTEIN JA
      THE EXTENT AND TIMING OF EARLY (CD34-) HEMATOPOIETIC PROGENITOR MOBILIZATION FOLLOWING CHEMOTHERAPY AND(CD33)OR PRIMING/

      Blood
    32. ROSS AA; MILLER GW; MOSS TJ; KAHN DG; WARNER NE; SWEET DL; LOUIE KG; SCHNEIDERMANN E; PECORA AL; MEAGHER RC; HERZIG RH; COLLINS RH; FAY JW
      IMMUNOCYTOCHEMICAL DETECTION OF TUMOR-CELLS IN BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL COLLECTIONS FROM PATIENTS WITH OVARIAN-CANCER

      Bone marrow transplantation
    33. ZAHOS KM; BROCHSTEIN JA; ISAACS RE; JENNIS AA; MURAWSKI JA; PECORA AL
      TEMPERATURE MAINTENANCE OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) BY DRY ICE

      Blood
    34. PECORA AL; BROCHSTEIN JA; JENNIS A; MICHELIS M; GRAZIOSO L; ZAHOS K; ISAACS RE
      TOTAL CD34- SUBSET PREDICT TIME TO NEUTROPHIL AND PLATELET ENGRAFTMENT AND HOSPITAL DISCHARGE IN PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY (HDC) WITH PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC)( CELL CONTENT AND CD34+CD33)

      Blood
    35. ZAHOS KM; PECORA AL; BROCHSTEIN J; JENNIS A; GRAZIOSO L; MICHELIS MA; ISAACS R
      EFFECT OF INTERFACE OFFSET (I O) ADJUSTMENT ON COLLECTION EFFICIENCY OF THE FENWAL CS-3000 BLOOD-CELL SEPARATOR FOR PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) COLLECTION/

      Blood
    36. BROCHSTEIN JA; PECORA AL; ZAHOS K; JENNIS A; VANVLIET A; GRAZIOSO L; CANTWELL S; MICHELIS M; ISAACS R
      AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOLLOWING BCNU, ETOPOSIDE, CYTARABINE AND CYCLOPHOSPHAMIDE (BVAC) FOR PATIENTS WITH RELAPSED LYMPHOMA

      Blood
    37. PECORA AL; BROCHSTEIN JA; ZAHOS K; GRAZIOSO L; VANVLIET A; MICHELIS M
      THE EFFECT OF PRIMED PERIPHERAL PROGENITOR CELLS (PPPC) ON HEMATOPOIETIC RECOVERY AND RESOURCE UTILIZATION IN AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT)

      Blood
    38. PECORA AL; BROCHSTEIN JA; VANVLIET A; ZAHOS K
      CARMUSTINE, ETOPOSIDE, CYTARABINE AND CYCLOPHOSPHAMIDE (BVAC) WITH AUTOLOGOUS STEM-CELL TRANSPLANT (SCT) FOR PATIENTS WITH CHEMOTHERAPY-SENSITIVE RELAPSED HODGKINS LYMPHOMA (HL) AND NON-HODGKINS-LYMPHOMA (NHL)

      Blood
    39. BROCHSTEIN JA; PECORA AL; VANVLIET A
      HIGH-DOSE ETOPOSIDE, THIOTEPA AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS MARROW SUPPORT FOR PEDIATRIC-PATIENTS WITH HIGH-RISK SOLID TUMORS

      Blood
    40. SPERBER SJ; GROSS PA; BONELLI J; VANVLIET A; BROCHSTEIN JA; PECORA AL
      SERUM ANTIBODY-TITERS TO INFLUENZA VACCINE (FLUV) IN AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) RECIPIENTS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 12:50:39